Balanceback is a prominent player in the Health Care industry, offering a clinical approach for diagnosing and treating balance disorders. Established in 2002 and headquartered in the United States, their mission revolves around providing a proven solution for identifying Vestibular from Neurological-based conditions, traumatic brain injury, and concussions. Their cutting-edge VNG technology and proprietary intuitive therapy system have positioned them as The World's Leader In Fall Prevention & CNS Disorders. With a focus on clinicians' needs, their solutions are designed, engineered, and manufactured in the USA. Despite their remarkable offerings, there is no publicly disclosed information regarding their last investment or the involved investors. As a Venture capital entity, determining the potential for investment and the market positioning of Balanceback would require additional insights.
There is no investment information
No recent news or press coverage available for balanceback.